Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05056207 · ClinicalTrials.gov registry record · NA
PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema
A NA study of Lymphedema, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT05056207 is a NA study of Lymphedema that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 260 participants, below the 9,292-participant average among 34 other Lymphedema trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05056207, a NA study of Lymphedema, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is to learn about breast cancer patients' opinions about screening for lymphedema (a side effect of breast cancer treatment in which the arm can become heavy, painful, and/or swollen) and their satisfaction with the lymphedema screening program.
Conditions Studied
Interventions
- OTHER Cohort I (patients receiving annual lymphedema screening
- OTHER Cohort II (patients followed intensively for lymphedema)
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2017-11-17 |
| Est. Completion | 2026-11-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05056207
The ClinicalTrials.gov registry entry for NCT05056207 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,292-participant average among 34 other Lymphedema trials with a reported enrollment target (97% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphedema appearing as the primary indexed condition, and to 2 interventions - of which Cohort I (patients receiving annual lymphedema screening is the first listed.
NCT05056207 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05056207 about?
NCT05056207 is a clinical study titled "PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema". This research study is to learn about breast cancer patients' opinions about screening for lymphedema (a side effect of breast cancer treatment in which the arm can become heavy, painful, and/or swollen) and their satisfaction with the lymphedema screening program.
What is the current status of trial NCT05056207?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2017-11-17. Estimated completion is 2026-11-17.
What conditions does trial NCT05056207 study?
This clinical trial studies the following conditions: Lymphedema.
What interventions are being tested in trial NCT05056207?
The interventions under investigation include: Cohort I (patients receiving annual lymphedema screening (OTHER), Cohort II (patients followed intensively for lymphedema) (OTHER).
Who is sponsoring clinical trial NCT05056207?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05056207 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
RECRUITING · NA
-
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
RECRUITING · NA
-
Pedal Pump and Leg Lymphedema
RECRUITING · NA
-
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITING · NA
-
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.